S. Edgerton
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 4
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 1
- Colorectal Cancer Treatments and Studies 1
-
- Monoclonal and Polyclonal Antibodies Research 2
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Ann D. Thor (8 shared papers)Dan H. Moore (2 shared papers)Christopher C. Benz (2 shared papers)David N. Louis (2 shared papers)E. Tessa Hedley‐Whyte (1 shared paper)Michael P. DiGiovanna (1 shared paper)David F. Stern (1 shared paper)Lawrence H. Schwartz (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)JNCI Journal of the National Cancer Institute (1 paper)Journal of Neuropathology & Experimental Neurology (1 paper)Acta Neuropathologica (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
S. Edgerton
8 papers receiving 545 citations
Peers
Comparison fields: 5 of 67
- Oncology 292
- Cancer Research 118
- Genetics 74
- Radiology, Nuclear Medicine and Imaging 152
- Immunology and Allergy 26
Countries citing papers authored by S. Edgerton
This map shows the geographic impact of S. Edgerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Edgerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Edgerton more than expected).
Fields of papers citing papers by S. Edgerton
This network shows the impact of papers produced by S. Edgerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Edgerton. The network helps show where S. Edgerton may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Edgerton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 147 | |
| 2 | 1991 | 136 | |
| 3 | 1991 | 123 | |
| 4 | 2004 | 83 | |
| 5 | 1995 | 63 | |
| 6 | 2009 | 6 | |
| 7 | 2009 | 1 | |
| 8 | 1990 | 1 |
About S. Edgerton
S. Edgerton is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 8 papers that have together received 560 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Breast Lesions and Carcinomas (2 papers), Glioma Diagnosis and Treatment (2 papers), Neuroblastoma Research and Treatments (2 papers), Cancer Treatment and Pharmacology (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (292 citations), Cancer Research (118 citations), Genetics (74 citations), Radiology, Nuclear Medicine and Imaging (152 citations) and Immunology and Allergy (26 citations). S. Edgerton has collaborated with scholars based in United States and Canada. Frequent co-authors include Ann D. Thor, Dan H. Moore, Christopher C. Benz, David N. Louis, E. Tessa Hedley‐Whyte, Michael P. DiGiovanna, David F. Stern, Lawrence H. Schwartz, Eileen Hickey and Brian H. Mayall. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Journal of Neuropathology & Experimental Neurology, Acta Neuropathologica and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.